ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382035; 2) Community: the network communities that were significantly associated with the response to NSC 382035; 3) Molecule: the relationships between components within communities and NSC 382035; 4) MDR: the compounds that were significantly associated with the NSC 382035.

NSC Compound Enrichment Correlation
NSC 757113 METHOTREXATE(+/-) 0.000174252554411808 0.76675834
NSC 368390 Brequinar 0.000176661849797006 0.82743199
NSC 382046 Null 0.000176661849797006 0.93633548
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.000284051704014449 0.8260546
NSC 726441 4,11-dihydroxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-naphtho [2,3-f]indole-5,10-dione dihydrochloride 0.000284051704014449 0.38681705
NSC 652565 Null 0.000316293616993019 0.49501977
NSC 762583 Null 0.000316293616993019 -0.12227864
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.000337797539144495 0.59724227
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.000455867606843412 0.8379062
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.000455867606843412 0.82777959
Total:112  Current:3    [First] [Prev] [Next] [Last]